Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
PainFever
Interventions
DRUG

IV Acetaminophen

Target is 1 to 7 days of therapy with intravenous (IV) Acetaminophen (IV APAP) at a dose of 40 to 75 mg/kg body weight/day administered as an IV infusion (or by syringe pump) over 15 minutes and given every 4 to 6 hours as a scheduled dose

Trial Locations (14)

10021

Hospital for Special Surgery, New York

11794

SUNY Stony Brook, Stony Brook

15213

University of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

19107

Thomas Jefferson University, Philadelphia

19803

Alfred Dupont Hospital for Children, Wilmington

20010

Children's National Medical Center, Washington D.C.

21287

Johns Hopkins University, Baltimore

48109

University of Michigan Ann Arbor, Ann Arbor

65212

University of Missouri, Columbia

77030

Baylor College of Medicine, Houston

77401

Houston Neonatal-Perinatal Physicians, Bellaire

94305

Lucile Salter Packard Children's Hospital at Stanford, Stanford

97239

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY